The Innovative Targets Portfolio: Basic Life Sciences Research to Novel Therapies, Through a Portfolio of Small Molecule Translational Projects (Confidence in Concept award)

Ferguson, Michael (Investigator)
Woodland, Andrew (Investigator)
Wyatt, Paul (Investigator)

Project Details

Status	Finished
Effective start/end date	1/03/15 → 31/08/16

Funding

Medical Research Council (MC_PC_14099 V 2): £700,000.00

1 Article

Targeting Mycobacterium tuberculosis CoaBC through Chemical Inhibition of 4'-Phosphopantothenoyl-l-cysteine Synthetase (CoaB) Activity
Evans, J. C., Murugesan, D., Post, J. M., Mendes, V., Wang, Z., Nahiyaan, N., Lynch, S. L., Thompson, S., Green, S. R., Ray, P. C., Hess, J., Spry, C., Coyne, A. G., Abell, C., Boshoff, H. I. M., Wyatt, P. G., Rhee, K. Y., Blundell, T. L., Barry, C. E. & Mizrahi, V., 3 May 2021, (E-pub ahead of print) In: ACS Infectious Diseases. 14 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
3 Downloads (Pure)